Clinical Trial Update: Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids [Phase 1]

View source ↗

Summary

Phase 1 trial comparing sirolimus to tacrolimus for long-term, steroid-free therapy in kidney transplant patients, focusing on safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Prograf (Tacrolimus) (Tacrolimus)
• Rapamune (sirolimus) (sirolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Diseases | Phase 1 | Status: COMPLETED